Contents    Cover    Publication Date: 23 Oct 2019
Year 2019 - Volume 29 - Issue 3

Open Access

Peer Reviewed

ORIGINAL RESEARCH
761 Viewed280 Downloaded

Does Endometriosis Impact the Prognosis of Endometrial Cancer?

Full Text PDF  
J Clin Obstet Gynecol. 2019;29(3):88-93
DOI: 10.5336/jcog.2019-70088
Article Language: EN
Copyright Ⓒ 2020 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Objective: Despite the well-known relationship between endometriosis and the risk and prognosis of ovarian cancer, studies on the association the two are rare. Moreover, the impact of endometriosis on the prognosis of endometrial cancer has not been described in the literature. In this study, we attempted to investigate whether endometriosis had an effect on the prognosis of endometrial cancer. Material and Methods: This retrospective study was carried out on data from endometrial cancer patients between January 1996 and February 2016 at the Gynecological Oncology Department of Çukurova University Balcalı Hospital in Adana, Turkey. The pathological reports of 920 cases, operated after the diagnosis of endometrial cancer, were screened. Among these cases, 764 patients were found to be eligible for enrollment in this study. The patients were distributed into two groups based on the presence or absence of endometriosis in the pathological materials. The prognosis of the groups was compared using the Kaplan-Meier method. Results: The endometriosis group was associated with younger age, less parity, more infertility, and a higher risk of simultaneous ovarian cancer. There were non-significant differences between the groups regarding pathological risk factors such as myometrial invasion, lymphovascular space involvement, lymph node positivity, and stage of progression. No recurrences or deaths were observed in the endometriosis group, although this observation was not statistically significant. Conclusion: It is suggested that endometriosis does not influence the prognosis of endometrial cancer. However, a conclusive assessment could not be made by this study alone and, therefore, further studies are needed and researchers are encouraged to focus more on this subject.
REFERENCES:
  1. Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ. 2014;348:g1752. [Crossref] [PubMed]
  2. Interinstitutional group of Mexican postgraduate students. CONACYT's freeze on postgraduate fellowships in Mexico. Lancet. 2017;389(10087):2373-4. [Crossref]
  3. Melin A, Lundholm C, Malki N, Swahn ML, Sparen P, Bergqvist A. Endometriosis as a prognostic factor for cancer survival. Int J Cancer. 2011;129(4):948-55. [Crossref] [PubMed]
  4. Yu HC, Lin LY, Chang WC, Shen BJ, Chang WP, Chuang CM; Task Force on Carcinogenesis of Endometrial Cancer. Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study. Int J Gynecol Cancer. 2015;25(3):447-52. [Crossref] [PubMed] [PMC]
  5. Stern RC, Dash R, Bentley RC, Snyder MJ, Haney AF, Robboy SJ. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol. 2001;20(2):133-9. [Crossref] [PubMed]
  6. Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol. 2001;83(2):355-62. [Crossref] [PubMed]
  7. Poole EM, Lin WT, Kvaskoff M, De Vivo I, Terry KL, Missmer SA. Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses. Cancer Causes Control. 2017;28(5):437-45. [Crossref] [PubMed] [PMC]
  8. Kurman RJ, Shih IeM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum Pathol. 2011;42(7):918-31. [Crossref] [PubMed] [PMC]
  9. McConechy MK, Anglesio MS, Kalloger SE, Yang W, Senz J, Chow C, et al. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas. J Pathol. 2011;223(5):567-73. [Crossref] [PubMed]
  10. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997;176(3):572-9. [Crossref]
  11. Zucchetto A, Serraino D, Polesel J, Negri E, De Paoli A, Dal Maso L, et al. Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev. 2009;18(4):316-21. [Crossref] [PubMed]
  12. Mogensen JB, Kjaer SK, Mellemkjaer L, Jensen A. Endometriosis and risks for ovarian, endometrial and breast cancers: a nationwide cohort study. Gynecol Oncol. 2016;143(1):87-92. [Crossref] [PubMed]
  13. Munksgaard PS, Blaakaer J. The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol Oncol. 2011;123(1):157-63. [Crossref] [PubMed]
  14. Rowlands IJ, Nagle CM, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group, Australian Ovarian Cancer Study Group. Gynecological conditions and the risk of endometrial cancer. Gynecol Oncol. 2011;123(3):537-41. [PubMed]
  15. Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjaer SK, Graubard BI, et al. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev. 2005;14(12):2929-35. [Crossref] [PubMed]
  16. Melin A, Sparen P, Persson I, Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod. 2006;21(5):1237-42. [Crossref] [PubMed]
  17. Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA. Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study. Cancer. 2002;94(5):1612-8. [Crossref] [PubMed]
  18. Melin A, Sparen P, Bergqvist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod. 2007;22(11):3021-6. [Crossref] [PubMed]
  19. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet. 1999;354(9190):1586-90. [Crossref]
  20. Borgfeldt C, Andolf E. Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand. 2004;83(4):395-400. [Crossref] [PubMed]
  21. Kok VC, Tsai HJ, Su CF, Lee CK. The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study. Int J Gynecol Cancer. 2015;25(6):968-76. [Crossref] [PubMed]